These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35935979)

  • 1. A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma.
    Chen B; Yao Y; Mao D; Li C; Wang X; Sheng S; Zhang L; Wang X; Chen S; Xu W; Deng J; Sun C; Zhou Q; Lowe S; Bentley R; Shao W; Li H
    Front Immunol; 2022; 13():928742. PubMed ID: 35935979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
    Zhou R; Peng N; Li W
    Front Immunol; 2022; 13():964919. PubMed ID: 36059494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A costimulatory molecule-related signature in regard to evaluation of prognosis and immune features for clear cell renal cell carcinoma.
    Hua X; Ge S; Zhang J; Xiao H; Tai S; Yang C; Zhang L; Liang C
    Cell Death Discov; 2021 Sep; 7(1):252. PubMed ID: 34537809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

  • 6. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma.
    Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X
    Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
    Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
    Front Oncol; 2021; 11():612952. PubMed ID: 34235071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
    Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
    Front Immunol; 2022; 13():854785. PubMed ID: 35392086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a fatty acid metabolism-related gene signature to predict prognosis in stomach adenocarcinoma.
    Liu L; Sun J; Zhong C; Zhang A; Wang G; Chen S; Zhang S; Wang M; Li L
    Aging (Albany NY); 2024 May; 16(10):8552-8571. PubMed ID: 38742949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic costimulatory molecule-related signature risk model correlates with immunotherapy response in colon cancer.
    Huang W; Su D; Liao X; Yang T; Lu Y; Zhang Z
    Sci Rep; 2023 Jan; 13(1):789. PubMed ID: 36646765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a prognostic metabolic signature in stomach adenocarcinoma.
    Gong Y; Wu S; Dong S; Chen S; Cai G; Bao K; Yang H; Jiao Y
    Clin Transl Oncol; 2022 Aug; 24(8):1615-1630. PubMed ID: 35355155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implication and immunotherapy response prediction of a costimulatory molecule signature in kidney renal clear cell carcinoma.
    Lin G; Yang Y; Feng Q; Zhan F; Sun C; Niu Y; Li G
    Immunogenetics; 2022 Jun; 74(3):285-301. PubMed ID: 35119508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiological signatures and the emerging role of SPP1 in predicting tumor heterogeneity, malignancy, and clinical outcomes in stomach adenocarcinoma.
    Wu Y; Ren L; Tang Y; Zhu Z; Liu S; Jiang Y; Zhang S; Zhuang X; Chen Y
    Aging (Albany NY); 2023 Oct; 15(20):11588-11610. PubMed ID: 37889539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma.
    Wang Y; Zhang X; Dai X; He D
    Expert Rev Anticancer Ther; 2021 Oct; 21(10):1161-1170. PubMed ID: 34319826
    [No Abstract]   [Full Text] [Related]  

  • 15. A degradome-related signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma based on machine learning procedure.
    Deng Z; Feng Q; Zhao D; Huang Z
    Medicine (Baltimore); 2024 Apr; 103(15):e37728. PubMed ID: 38608069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
    Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
    Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
    Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
    DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of the molecular subtypes and a risk model for stomach adenocarcinoma based on genes related to reactive oxygen species.
    Li G; Ping M; Zhang W; Wang Y; Zhang Z; Su Z
    Heliyon; 2024 Mar; 10(5):e27079. PubMed ID: 38463816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of the Prognostic Significance of Hsa-miR-100-5p and Its Related Gene Signature in Stomach Adenocarcinoma.
    Wang G; Yang L; Hu M; Hu R; Wang Y; Chen B; Jiang X; Cui R
    Front Cell Dev Biol; 2021; 9():736274. PubMed ID: 34604236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel microRNA signature predicts survival in stomach adenocarcinoma.
    Ding B; Gao X; Li H; Liu L; Hao X
    Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.